Analystreport

Mirum Pharmaceuticals (MIRM) had its price target raised by Robert W. Baird from $95.00 to $112.00. They now have an "outperform" rating on the stock.

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report